Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [6297]

Scientists develop one-product-fits-all immunotherapy for breast cancer

Scientists develop one-product-fits-all immunotherapy for breast cancer

New genomic test could spare some people with melanoma from lymph node biopsy surgery

New genomic test could spare some people with melanoma from lymph node biopsy surgery

Researchers develop a less invasive, more effective method to analyse immunotherapy efficacy

Researchers develop a less invasive, more effective method to analyse immunotherapy efficacy

ESMO 2025: Roundup of MSK's research, including lung and pancreatic cancer treatments

ESMO 2025: Roundup of MSK's research, including lung and pancreatic cancer treatments

Biomarker analysis reveals clues to long-term survival in glioblastoma patients treated with SurVaxM

Biomarker analysis reveals clues to long-term survival in glioblastoma patients treated with SurVaxM

Acute myeloid leukemia (AML): Disease risk but not remission status determines transplant outcomes – new ASAP long-term results

Acute myeloid leukemia (AML): Disease risk but not remission status determines transplant outcomes – new ASAP long...

Laser targets pancreatic tumours by homing in on collagen

Laser targets pancreatic tumours by homing in on collagen

Short-course radiation therapy after prostate surgery helps keep cancer from returning

Short-course radiation therapy after prostate surgery helps keep cancer from returning

FDA approves lurbinectedin in combination with atezolizumab or atezolizumab and hyaluronidase-tqjs for extensive-stage small cell lung cancer

FDA approves lurbinectedin in combination with atezolizumab or atezolizumab and hyaluronidase-tqjs for extensive...

Genetic “Trojan horse” selectively kills cancer cells linked to Kaposi’s sarcoma

Genetic “Trojan horse” selectively kills cancer cells linked to Kaposi’s sarcoma

More from ecancer